Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in Mice

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ahmad, Akbar ^a   Crupi, Rosalia ^a   Campolo, Michela ^a   Genovese, Tiziana ^a   Esposito, Emanuela ^a   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CHYMASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 4; TRYPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DENSITOMETRY; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INFARCTION; BRAIN INJURIES; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1BETA; MAP KINASE KINASE 4; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; POLY(ADP-RIBOSE) POLYMERASES; TOLL-LIKE RECEPTOR 4; TRYPTASES; TYROSINE;

MUS;

EID: 84875489498     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057208     Document Type: Article

References (57)

1. Dutton RP, Stansbury LG, Leone S, Kramer E, Hess J, et al. (2010) Trauma mortality in mature trauma systems: are we doing better? An analysis of trauma mortality patterns, 1997-2008. J Trauma 69: 620-626.
2. Bramlett HM, Dietrich WD, (2007) Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res 161: 125-141.
3. Panter SS, Faden AI, (1992) Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci Lett 136: 165-168.
4. Loane DJ, Faden AI, (2010) Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 31: 596-604.
5. Akira S, (2006) TLR signaling. Curr Top Microbiol Immunol 311: 1-16.
6. Poltorak A, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
7. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, et al. (1997) Identification and characterization of an IkappaB kinase. Cell 90: 373-383.
8. Hwang D, (2001) Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. Faseb J 15: 2556-2564.
9. O'Neill LA, (2003) The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem Soc Trans 31: 643-647.
10. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7): 499-511.
11. Mishra BB, Gundra UM, Teale JM, (2008) Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. J Neuroinflammation 5: 53.
12. Owens T, Babcock AA, Millward JM, Toft-Hansen H, (2005) Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res Brain Res Rev 48: 178-184.
13. Trendelenburg G, (2008) Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response? J Cereb Blood Flow Metab 28: 867-881.
14. Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K, (2008) Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation 5: 23.
15. Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, et al. (2009) Toll-like receptors in neurodegeneration. Brain Res Rev 59: 278-292.
16. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, et al. (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17: 1304-1308.
17. Schomacher M, Müller HD, Sommer C, Schwab S, Schäbitz WR, (2008) Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res 1240: 213-220.
18. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, et al. (1997) Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A 94: 2007-2012.
19. Schabitz WR, Li F, Irie K, Sandage BW Jr, Locke KW, et al. (1999) Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke 30: 427-431; discussion 431-432.
20. Sirin BH, Ortaç R, Cerrahoǧlu M, Saribülbül O, Baltalarli A, et al. (2002) Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol 57: 279-285.
21. Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, et al. (2001) Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan. Shock 16: 51-58.
22. Shea TB, (1994) Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. Biotechniques 16: 1126-1128.
23. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, et al. (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 18: 3251-3260.
24. Yu TS, Zhang G, Liebl DJ, Kernie SG, (2008) Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors. J Neurosci 28: 12901-12912.
25. Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, et al. (2005) Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A 102: 8333-8338.
26. Fawcett JW, Asher RA, (1999) The glial scar and central nervous system repair. Brain Res Bull 49: 377-91.
27. Lawson LJ, Perry VH, Dri P, Gordon S, (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151-170.
28. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al. (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 100: 8514-8519.
29. Jou I, Lee JH, Park SY, Yoon HJ, Joe EH, et al. (2006) Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol 168: 1619-1630.
30. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, et al. (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 104: 13798-13803.
31. Gordon JR, Galli SJ, (1991) Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 174: 103-107.
32. Kownatzki E, (1982) Triggering of mast cells. Mol Immunol 19: 1297-1300.
33. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, et al. (1997) Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8: 2631-2645.
34. Kielian T, (2006) Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83: 711-730.
35. Farina C, Aloisi F, Meinl E, (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol 28: 138-145.
36. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I, Walter J, et al. (2005) Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP [V717I] transgenic mice. J Neuroinflammation 2: 22.
37. Vanzani MC, Iacono RF, Caccuri RL, Berria MI, (2005) Immunochemical and morphometric features of astrocyte reactivity vs. plaque location in Alzheimer's disease. Medicina (B Aires) 65: 213-218.
38. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A, (2009) Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16: 378-385.
39. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, et al. (2006) Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A 103: 17513-17518.
40. Chvatal A, Anderová M, Hock M, Prajerová I, Neprasová H, et al. (2007) Three-dimensional confocal morphometry reveals structural changes in astrocyte morphology in situ. J Neurosci Res 85: 260-271.
41. Barcia C, Sanderson NS, Barrett RJ, Wawrowsky K, Kroeger KM, et al. (2008) T cells' immunological synapses induce polarization of brain astrocytes in vivo and in vitro: a novel astrocyte response mechanism to cellular injury. PLoS One 3: e2977.
42. Glezer I, Chernomoretz A, David S, Plante MM, Rivest S, (2007) Genes involved in the balance between neuronal survival and death during inflammation. PLoS One 2: e310.
43. Glezer I, Simard AR, Rivest S, (2007) Neuroprotective role of the innate immune system by microglia. Neuroscience 147: 867-883.
44. Aloisi F, (2001) Immune function of microglia. Glia 36: 165-179.
45. Ziebell JM, Morganti-Kossmann MC, (2010) Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7: 22-30.
46. Medzhitov R, Preston-Hurlburt P, Janeway CA, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
47. Lee JY, Lowell CA, Lemay DG, Youn HS, Rhee SH, et al. (2005) The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4. Biochem Pharmacol 70: 1231-1240.
48. Gahm C, Holmin S, Wiklund PN, Brundin L, Mathiesen T, et al. (2006) Neuroprotection by selective inhibition of inducible nitric oxide synthase after experimental brain contusion. J Neurotrauma 23: 1343-1354.
49. Iadecola C, et al. (1995) Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 15: 378-384.
50. Xu J, Kim GM, Chen S, Yan P, Ahmed SH, et al. (2001) iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma 18: 523-532.
51. Zerfaoui M, Errami Y, Naura AS, Suzuki Y, Kim H, et al. (2010) Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J Immunol 185: 1894-1902.
52. Szabo C, Dawson VL, (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19: 287-298.
53. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, et al. (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736.
54. Bar-Peled O, Knudson M, Korsmeyer SJ, Rothstein JD, (1999) Motor neuron degeneration is attenuated in bax-deficient neurons in vitro. J Neurosci Res 55: 542-556.
55. Cao G, Pei W, Ge H, Liang Q, Luo Y, et al. (2002) In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. J Neurosci 22: 5423-5431.
56. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
57. Kawai T, Akira S, (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13: 460-469.